Key Drivers and Opportunities in the Gastric Volvulus Treatment Market: Insights into Trends and Growth
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Significant is the Anticipated Growth Rate of the Gastric Volvulus Treatment Market from 2025 to 2034?
In recent times, the market size for gastric volvulus treatment has shown significant growth. Projected to rise from $27.36 billion in 2024, it is expected to amount to $28.95 billion in 2025 with a compound annual growth rate (CAGR) of 5.8%. This growth in the preceding years has been linked to advancements in surgical methodologies, enhanced diagnostic technologies, an increase in public awareness and education, growth in minimally invasive procedures, as well as ongoing research and clinical studies.
Anticipated to experience robust expansion in the coming years, the market size for gastric volvulus treatment is predicted to hit a high of $37.48 billion in 2029, boasting a compound annual growth rate (CAGR) of 6.7%. Growth forecasted for this period is primarily due to regulatory alterations and endorsements, advancements in surgical techniques, an aging population, personalized treatment strategies, and the increased use of sophisticated imaging methods. Key trends for this forecast period encompass minimally invasive surgical procedures, deliberate awareness and early action, research pivoted around treatment modalities, collaborative healthcare practices, and targeted treatment methodologies.
Which Macro and Microeconomic Factors Are Accelerating the Growth of the gastric volvulus treatment Market?
The expansion of the gastric volvulus treatment market is anticipated to be fueled by the growing geriatric population. This group encompasses those who are 65 years of age and above. Various diseases, including gastric volvulus, are common in this demographic due to their lowered immunity and old age. Gastric volvulus is particularly rampant among individuals that are above 50 years old. Therefore, the growing number of geriatric individuals is predicted to enhance the market. For example, projections by the Population Reference Bureau (PRB), a nonprofit entity based in the US, in January 2024 suggested that there would be a substantial increase in Americans aged 65 and older. The figures were expected to rise from 58 million in 2022 to around 82 million in 2050, a surge of 47%. Their share of the total population was also set to rise from 17% to 23%. Consequently, the burgeoning geriatric population is a catalyst for the growth of the gastric volvulus treatment market.
Request Your Free Gastric Volvulus Treatment Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp
What Are the Key Firms That Are Driving Transformation in the Gastric Volvulus Treatment Market?
Major companies operating in the gastric volvulus treatment market include:
• PAI Pharma_x000D_
• Sun Pharmaceutical Industries Ltd._x000D_
• ANI Pharmaceuticals Inc._x000D_
• Fresenius SE and Co. KGaA_x000D_
• Mayne Pharma Group Limited_x000D_
What Current Trends in the Gastric Volvulus Treatment Market Should Industry Players Pay Attention To?
The emergence of product innovations is a notable trend making waves in the gastric volvulus treatment market. To maintain their market standing, key companies are debuting unique products. For example, Pfizer Inc., a pharmaceutical company based in the U.S, announced the approval of VELSIPITY (etrasimod) by the U.S. Food and Drug Administration (FDA) in October of 2023. Designed as a daily, oral-based sphingosine-1-phosphate (S1P) receptor activator, VELSIPITY is intended for those suffering from moderate to severe active ulcerative colitis (UC). The suggested usage of VELSIPITY is 2 mg and is represented as a hopeful means for adults fighting moderate to severe active UC to achieve a steroid-free resolution. As an added bonus, this once-daily pill possesses an encouraging benefit-risk ratio. The FDA’s green-lighting of VELSIPITY signifies a pivotal shift for UC sufferers who need innovative treatments for their chronic illness and are prepared to commence heightened therapy.
Pre-order Your Report for Quick and Easy Delivery!
https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report
Which Key Segments Define the Structure of the Gastric Volvulus Treatment Market and Their Growth Potential?
The gastric volvulus treatment market covered in this report is segmented –
1) By Type: Organo-Axial Volvulus, Mesentero-Axial Volvulus
2) By Treatment Type: Medication, Surgery
3) By Route Of Administration: Oral, Parenteral
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy
5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users
Subsegments:
1) By Organo-Axial Volvulus: Surgical Intervention, Endoscopic Management, Gastropexy, Other Treatment Methods
2) By Mesentero-Axial Volvulus: Surgical Intervention, Gastropexy, Endoscopic Techniques, Other Treatment Approaches
What Regions Are Driving Expansion in the Gastric Volvulus Treatment Market?
North America was the largest region in the gastric volvulus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in the gastric volvulus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
How Is the Gastric Volvulus Treatment Market Categorized and Defined in the Industry?
Gastric volvulus treatment refers to surgical treatment, specifically volvulus reduction, reintegration of the stomach into the abdominal cavity in cases of intrathoracic migration, and correction of causal factors. Gastric volvulus surgery is usually simple, involving de-rotation, lowering of the hernial contents into the abdominal wall, and repair of the hernial defect.
Browse Through More Similar Reports By The Business Research Company:
Patient Blood Management Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report
Conjugated Monoclonal Antibodies Global Market Report 2024
Anemia And Other Blood Disorder Drugs Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
